TY  - JOUR
A1  - Eilmann, Britta
A1  - Zweifel, Roman
A1  - Buchmann, Nina
A1  - Graf Pannatier, Elisabeth
A1  - Rigling, Andreas
T1  - Drought alters timing, quantity, and quality of wood formation in Scots pine
JF  - Journal of Experimental Botany
Y1  - 2011
U6  - https://doi.org/10.1093/jxb/erq443
SN  - 1460-2431 (Online)
SN  - 0022-0957 (Print)
VL  - 62
IS  - 8
SP  - 2763
EP  - 2771
PB  - Oxford University Press
CY  - Oxford
ER  - 
TY  - JOUR
A1  - Anik, Sabri
A1  - Frohberg, Martin G.
A1  - Kapoor, Madan Lal
T1  - Prediction of thermodynamic properties of oxygen in binary metallic solvents
JF  - Zeitschrift für Metallkunde
Y1  - 1983
SN  - 0044-3093
VL  - 74
IS  - 6
SP  - 372
EP  - 375
ER  - 
TY  - CHAP
A1  - Gebhardt, Andreas
A1  - Ritz, Thomas
A1  - Siekmann, Kirsten
A1  - Wallenborn, Ramona
ED  - Demmer, Axel
T1  - Additive manufacturing businesses in the process chain of individualized mass products
T2  - DDMC 2014 : Proceedings of the Fraunhofer Direct Digital Manufacturing Conference
Y1  - 2014
SN  - 978-3-8396-9128-1 (E-Book)
PB  - Fraunhofer
CY  - Stuttgart
ER  - 
TY  - JOUR
A1  - Bragard, Michael
A1  - Soltau, N.
A1  - Thomas, S.
A1  - De Doncker, R. W.
T1  - The balance of renewable sources and user demands in grids : power electronics for modular battery energy storage systems
JF  - IEEE transactions on power electronics
N2  - The continuously growing amount of renewable sources starts compromising the stability of electrical grids. Contradictory to fossil fuel power plants, energy production of wind and photovoltaic (PV) energy is fluctuating. Although predictions have significantly improved, an outage of multi-MW offshore wind farms poses a challenging problem. One solution could be the integration of storage systems in the grid. After a short overview, this paper focuses on two exemplary battery storage systems, including the required power electronics. The grid integration, as well as the optimal usage of volatile energy reserves, is presented for a 5- kW PV system for home application, as well as for a 100- MW medium-voltage system, intended for wind farm usage. The efficiency and cost of topologies are investigated as a key parameter for large-scale integration of renewable power at medium- and low-voltage.
Y1  - 2010
U6  - https://doi.org/10.1109/TPEL.2010.2085455
SN  - 0885-8993
VL  - 25
IS  - 12
SP  - 3049
EP  - 3056
PB  - IEEE
CY  - New York
ER  - 
TY  - CHAP
A1  - Ringbeck, Thorsten
A1  - Schwarte, Rudolf
A1  - Buxbaum, Bernd
A1  - Hess, Rudolf
ED  - Tang, Suning
T1  - Optical GMSK modem for infrared wireless communication based on a new receiver principle in CMOS technology
T2  - Optoelectronic interconnects VIII : 25 - 26 January 2001, San Jose, USA. - (Proceedings of SPIE ; 4292)
Y1  - 2001
SN  - 0-8194-3970-3
SN  - 0038-7355
SN  - 0361-0748
SN  - 0277-786X
N1  - Optoelectronic Interconnects <8, 2001, San Jose, Calif.>
SP  - 25
EP  - 34
PB  - SPIE
CY  - Bellingham, Wash.
ER  - 
TY  - JOUR
A1  - Nokihara, Kiyoshi
A1  - Berndt, Heinz
T1  - Synthesis of hapten–polypeptide conjugates as antigen models for the N-terminal region of the α-2-chain of rabbit skin collagen
JF  - Journal of the Royal Society of Chemistry: Perkin Transactions 1
N2  - Synthesis of derivatives of the peptide sequence L-pyroglutamyl-L-phenylalanyl-L-aspartyl-glycyl-L-lysyl-glycyl-glycyl-glycine as the antigenic determinant representing the N-terminal non-helical region of the α-2-chain of rabbit skin collagen, and conjugation to two different polypeptide carriers, are described.
Y1  - 1978
U6  - https://doi.org/10.1039/P19780000260
SN  - 1364-5463
SN  - 0300-922X
SN  - 1470-4358
VL  - 1978
IS  - 3
SP  - 260
EP  - 263
PB  - Royal Society of Chemistry
CY  - Cambridge
ER  - 
TY  - CHAP
A1  - Kroggel, Matthias
A1  - Berndt, Heinz
ED  - Ragnarsson, Ulf
T1  - The 0-hydroxiphenyloxicarbonyl-group a new base labile amine protecting group
T2  - Peptides 1984 : Proceedings of the 18th European Peptide Symposium Djurönäset, Sweden, June 10 - 15, 1984
Y1  - 1984
SN  - 91-22-00715-6
SP  - 81
EP  - 83
PB  - Almquist & Wiksell
CY  - Stockholm
ER  - 
TY  - CHAP
A1  - Helmig, Ilka
ED  - Klanten, Robert
T1  - Tristan und Isolde, Samson und Dalila, Capriccio : 3D illustration for posters of Cologne Opera
T2  - Papercraft [1] : design and art with paper
KW  - Papierkunst
Y1  - 2009
SN  - 978-3-89955-251-5
SP  - 202
PB  - Gestalten Verlag
CY  - Berlin
ER  - 
TY  - JOUR
A1  - Scheer, Nico
A1  - Kapelyukh, Yury
A1  - Rode, Anja
A1  - Buechel, Sandra
A1  - Wolf, C. Roland
T1  - Generation and characterization of novel cytochrome P450 Cyp2c gene cluster knockout and CYP2C9 humanized mouse lines
JF  - Molecular Pharmacology
N2  - Compared with rodents and many other animal species, the human cytochrome P450 (P450) Cyp2c gene cluster varies significantly in the multiplicity of functional genes and in the substrate specificity of its enzymes. As a consequence, the use of wild-type animal models to predict the role of human CYP2C enzymes in drug metabolism and drug-drug interactions is limited. Within the human CYP2C cluster CYP2C9 is of particular importance, because it is one of the most abundant P450 enzymes in human liver, and it is involved in the metabolism of a wide variety of important drugs and environmental chemicals. To investigate the in vivo functions of cytochrome P450 Cyp2c genes and to establish a model for studying the functions of CYP2C9 in vivo, we have generated a mouse model with a deletion of the murine Cyp2c gene cluster and a corresponding humanized model expressing CYP2C9 specifically in the liver. Despite the high number of functional genes in the mouse Cyp2c cluster and the reported roles of some of these proteins in different biological processes, mice deleted for Cyp2c genes were viable and fertile but showed certain phenotypic alterations in the liver. The expression of CYP2C9 in the liver also resulted in viable animals active in the metabolism and disposition of a number of CYP2C9 substrates. These mouse lines provide a powerful tool for studying the role of Cyp2c genes and of CYP2C9 in particular in drug disposition and as a factor in drug-drug interaction.
Y1  - 2012
U6  - https://doi.org/10.1124/mol.112.080036
SN  - 1521-0111
VL  - 82
IS  - 6
SP  - 1022
EP  - 1029
PB  - ASPET
CY  - Bethesda, Md.
ER  - 
TY  - PAT
A1  - Nötzold, K.
A1  - Bragard, Michael
A1  - Fink, K.
A1  - Griessel, R.
A1  - Wegener, R.
T1  - Cascaded H-bridge converter with transformer based cell power balancing in each voltage level  : [Patentschrift]
Y1  - 2014
N1  - Titel des US-Patents: Bypassed cascaded cell converter : [patent of invention]. - Außerdem veröffentlicht als CN103997231 (A)
PB  - Europäisches Patentamt / United States Patent and Trademark Office [u.a.]
CY  - Den Haag / Alexandria, VA
ER  -